Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Gene Therapy00:59

Gene Therapy

27.6K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.6K
Second Order systems II01:18

Second Order systems II

406
In an underdamped second-order system, where the damping ratio ζ is between 0 and 1, a unit-step input results in a transfer function that, when transformed using the inverse Laplace method, reveals the output response. The output exhibits a damped sinusoidal oscillation, and the difference between the input and output is termed the error signal. This error signal also demonstrates damped oscillatory behavior. Eventually, as the system reaches a steady state, the error diminishes to zero.
406
First Order Systems01:21

First Order Systems

428
First-order systems, such as RC circuits, are foundational in understanding dynamic systems due to their straightforward input-output relationship. Analyzing their responses to different input functions under zero initial conditions reveals significant insights into system behavior.
When a first-order system is subjected to a unit-step input, its response is characterized by its transfer function. By applying the Laplace transform of the unit-step input to the transfer function, expanding the...
428
Second Order systems I01:20

Second Order systems I

599
A servo system exemplifies a second-order system, featuring a proportional controller and load elements that ensure the output position aligns with the input position. The relationship between these components is described by a second-order differential equation. Applying the Laplace transform under zero initial conditions yields the transfer function, showing how inputs are converted to outputs in the system.
By reinterpreting the system, one can derive the closed-loop transfer function, which...
599
Group Therapy01:26

Group Therapy

443
Group therapy is a sociocultural approach to psychological treatment, where individuals with shared psychological challenges come together under the guidance of a mental health professional. This therapeutic modality offers unique opportunities for individuals to connect, share, and grow within the context of a supportive group. By fostering mutual understanding and collaboration, group therapy can address a range of psychological concerns effectively, often complementing or surpassing the...
443
Thermodynamic Systems01:06

Thermodynamic Systems

8.0K
A thermodynamic system is a set of objects whose thermodynamic properties are of interest. The system is considered to be embedded in its surroundings or the environment. The system and its environment can exchange heat and do work on each other through a boundary that separates them. However, the immediate surroundings of the system interact with it directly and therefore have a much stronger influence on its behavior and properties.
Consider an example of  tea boiling in a kettle. The...
8.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient Engagement With an Electronic Patient-Reported Outcomes Tool Evaluating Hospital Discharge Readiness After Cancer Surgery.

JCO oncology practice·2026
Same author

Muscle Oxygenation, Performance, and Perceived Fatigability During Low-Intensity Isometric Exercise: Effects of Anchoring Strategy, Blood Flow Restriction, and Sex.

Journal of strength and conditioning research·2026
Same author

Beyond Routine Surveillance Imaging for Melanoma: Emerging Technologies for Detecting Early Recurrence and Guiding Clinical Management.

American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting·2026
Same author

Hierarchical Bayesian Analysis of Suicidal Ideation Among Middle-Aged and Older Adults in South Korea.

Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society·2026
Same author

Immunotherapy Administration and Survival for Stage IV Melanoma Patients at Minority-Serving Hospitals.

Cancer medicine·2026
Same author

Randomized Phase I/II Clinical Trial of a Melanoma Helper Peptide Vaccine with or without Systemic Agonistic Anti-CD27 Antibody (Varlilumab).

Cancer research communications·2026

Related Experiment Video

Updated: Feb 2, 2026

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
07:15

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

10.3K

Updates in adjuvant systemic therapy for melanoma.

Minyoung Kwak1, Norma E Farrow2, April K S Salama3

  • 1Department of Surgery, University of Virginia, Charlottesville, Virginia.

Journal of Surgical Oncology
|November 28, 2018
PubMed
Summary
This summary is machine-generated.

New adjuvant therapies are available for stage III/IV melanoma patients post-surgery. This review covers immune therapies, targeted treatments, and vaccines, aiding personalized treatment selection for advanced melanoma.

Keywords:
adjuvant therapymelanoma

More Related Videos

A Melanoma Patient-Derived Xenograft Model
07:07

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

13.2K
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.9K

Related Experiment Videos

Last Updated: Feb 2, 2026

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
07:15

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

10.3K
A Melanoma Patient-Derived Xenograft Model
07:07

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

13.2K
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.9K

Area of Science:

  • Oncology
  • Immunology
  • Dermatology

Background:

  • Adjuvant therapy use has rapidly increased for resected stages III/IV melanoma.
  • Current adjuvant indications encompass a diverse group of melanoma patients.

Purpose of the Study:

  • To review approved adjuvant therapies for stages III/IV melanoma.
  • To describe key clinical trials involving systemic immune therapies, targeted therapies, and vaccine strategies.
  • To provide evidence-based guidance for selecting optimal adjuvant treatment regimens.

Main Methods:

  • Literature review of pivotal clinical trials.
  • Analysis of systemic immune therapies, targeted therapies, and adjuvant vaccine strategies.
  • Discussion of evidence for personalized treatment selection.

Main Results:

  • Several systemic immune therapies, targeted therapies, and vaccine strategies have demonstrated efficacy.
  • Clinical trial data supports the use of various adjuvant treatment modalities.
  • Evidence exists to guide the selection of appropriate regimens for individual patients.

Conclusions:

  • Adjuvant therapy is increasingly important for resected melanoma.
  • A range of treatment options are available, requiring careful patient selection.
  • Personalized treatment strategies are crucial for optimizing outcomes in advanced melanoma.